Korro Bio Inc KRRO

$10.49 +0.73 (7.48%)

Valuation

Market cap
143,726,000
Revenue TTM
$6,390,000
Net income TTM
$-117,260,000
PE ratio
0.00
Forward PE
—
Profit margin
-1,835.05%
Debt to equity
0.00

Trading

Volume
156,900
Avg volume
141,212
Day's range
$9.50 – $10.64
Shares out
14,726,000
Stochastic %K
89%
Beta
3.13
Analysts
Strong Sell
Price target
$20.00

Price

Company profile

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA ed...

Show more

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 468 1999
Website
https://www.korrobio.com
Address
60 First Street, 2nd Floor Suite 250, Cambridge, United States

Latest news

Stocktwits

Emmetdeals Oct 8, 9:14 AM
I almost didn't take this one. Saw @swingSAGE_ alert then figured I'd give it a shot and came back to +15k$ I'm definitely paying attention to his calls now, I recommend u follow him too $KRRO $RMTI $BAER - next
0 replies
prismmarketview Oct 6, 1:38 PM
$KRRO: first cohort dosed in ANCHOR, Phase 1/2 trial of KRRO-121 (RNA-editing oligonucleotide) for hyperammonemia in UCDs → Single 2 mg/kg dose in healthy volunteers, currently enrolling in Australia → Phase 1: up to 50 healthy volunteers, placebo-controlled (SAD up to 30, MAD up to 20) → Phase 2: up to 15 UCD patients across all genotypes, subject to regulatory approval → Patient dosing 1H 2027, interim readout 2H 2027 Caveats: dosing only, no clinical results. Preclinical ammonia data not yet shown in humans. Safety and activity are the next tests. $KRRO #Biotech #RareDisease https://prismmarketview.com/korro-bio-begins-human-testing-of-rna-editing-therapy-for-urea-cycle-disorders/
0 replies
AudriusUK Oct 5, 12:45 PM
$KRRO is this alive ?
0 replies
svallab1 Sep 21, 11:13 PM
$KRRO looks like this board is dead? Not even a single message since 3 day decline? Can anyone ahed some light into what may have caused this drop? I thought 11.11 was the bottom
1 replies
Arcides Sep 17, 7:55 PM
$KRRO
0 replies
jazzv Sep 17, 6:30 PM
$KRRO wut happened? why the drop?
0 replies
StockConsultant Sep 14, 4:27 PM
$KRRO Korro Bio stock, strong day, watch for a range breakout at https://www.stockconsultant.com/?KRRO Breakout trade WATCH for possible breakout above 15.24 Target: 21.22, 41.3% Stop: 12.96 Loss: 13.7% P/L ratio: 3 : 1 - Good BULLISH [Timing] Strong bullish 3 day candlestick pattern with Strong 3 day accumulation. [Timing] Extreme bullish 1 day moneyflow [Timing] Breakout trade watch above 15.24, no resistance in area just above. BEARISH [Positioning] at resistance
0 replies
PhishTourFunds Sep 8, 8:29 PM
$KRRO There was a 1:50 r/s in 2023 that corrected the float ~ that gnarly wick down would be the exit liquidity ~ now the slow grind up with little sustained volume 👁️👁️ And now we have institutional hammer of inflow!
1 replies